Virax Biolabs Group Limited
Last updated September 27, 2026
Organization details
- Legal name
- Virax Biolabs Group Limited
- Former names
- Virax Biolabs (Cayman) Ltd
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2835 — In Vitro & In Vivo Diagnostic Substances
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- Lanarkshire
- Headquarters country
- United Kingdom
- Fiscal year end
- March
- Ticker symbol
- VRAX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001885827
Board of directors
-
Evan Michael Norton · DirectorSince 2026
-
Iain David Miller · DirectorSince 2026
-
Nelson M. Haight · DirectorSince 2026
-
Nigel William McCracken · Director · Chief Operating OfficerSince 2026
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Akanda Corp.
Nasdaq: AKAN · New Romney, United Kingdom
Organization
Akari Therapeutics plc
Nasdaq: AKTX · Tampa, United Kingdom
Organization
AstraZeneca PLC
NYSE: AZN · Cambridge, United Kingdom
Organization
Autolus Therapeutics plc American Depositary Share
Nasdaq: AUTL · London, United Kingdom
Organization
Questions about Virax Biolabs Group Limited
How many directors are on Virax Biolabs Group Limited's board?
Virax Biolabs Group Limited's board has 4 directors: Evan Michael Norton, Iain David Miller, Nelson M. Haight and Nigel William McCracken.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="virax-biolabs-group-limited"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.